Decision Period 8 Summary
When deciding which global distributors to use, we created our own Global Attractiveness Profile. We based our decisions on population, purchasing power parity (PPP), and potential expansion of each region and distributor. In the end, we decided to use distributors in Belgium/France, Japan, and India.
The first choice of distributors was Medicaments Durand SA (Belgium/France). Not only does the region have a large population, but its PPP is high. Also, the CEO, Ms. Mittere, has a track record of business success. Ms. Mittere is familiar with US commerce and has ties to the EU, which is important factor in PhisoTech’s international expansion.
The other two choices were Sumo Seyaku Ltd. (Japan) and Dawa (India). Mr. Tanaka, the CEO of Sumo Seyaku, and Lyndon, the CEO of Dawa, have a professional history, and they have discussed the potential opportunities of expansion in Japan. The population and PPP make Japan a promising market. India’s growing population is a market that PhisoTech cannot ignore. Although Mr. Dawa firmly believes in acupuncture to heal aches and pains, his knowledge the U.S. will be very valuable during PhisoTech’s expansion into India.
The other two choices were Sumo Seyaku Ltd. (Japan) and Dawa (India). Mr. Tanaka, the CEO of Sumo Seyaku, and Lyndon, the CEO of Dawa, have a professional history, and they have discussed the potential opportunities of expansion in Japan. The population and PPP make Japan a promising market. India’s growing population is a market that PhisoTech cannot ignore. Although Mr. Dawa firmly believes in acupuncture to heal aches and pains, his knowledge the U.S. will be very valuable during PhisoTech’s expansion into India.